Indeed, sterol response element-binding protein 1 (SREBP1) has been demonstrated to regulate hBCATm, in pancreatic ductal adenocarcinoma [50] and IDH1, but not IDH2 expression, in breast cancer [51]. This evidence concerns the gene SREBF1 and pancreatic ductal adenocarcinoma.